<?xml version="1.0" encoding="UTF-8"?>
<ref id="B84-pharmaceuticals-14-00381">
 <label>84.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Lu</surname>
    <given-names>D.Y.</given-names>
   </name>
   <name>
    <surname>Wu</surname>
    <given-names>H.Y.</given-names>
   </name>
   <name>
    <surname>Yarla</surname>
    <given-names>N.S.</given-names>
   </name>
   <name>
    <surname>Xu</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ding</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>T.R.</given-names>
   </name>
  </person-group>
  <article-title>HAART in HIV/AIDS Treatments: Future Trends</article-title>
  <source>Infect. Disord. Drug Targets</source>
  <year>2018</year>
  <volume>18</volume>
  <fpage>15</fpage>
  <lpage>22</lpage>
  <pub-id pub-id-type="doi">10.2174/1871526517666170505122800</pub-id>
  <?supplied-pmid 28474549?>
  <pub-id pub-id-type="pmid">28474549</pub-id>
 </element-citation>
</ref>
